|
|
Volumn 280, Issue 17, 1998, Pages 1472-
|
|
New drug to treat HIV/AIDS approved
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
EFAVIRENZ;
NUCLEOSIDE ANALOG;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
UNCLASSIFIED DRUG;
VIRUS RNA;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ETHINYLESTRADIOL;
LEVONORGESTREL;
OXAZINE DERIVATIVE;
POSTCOITUS CONTRACEPTIVE AGENT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL TRIAL;
CONGENITAL MALFORMATION;
DRUG EFFICACY;
DRUG RESISTANCE;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LYMPHOCYTE COUNT;
NEUROLOGIC DISEASE;
NONHUMAN;
PRIORITY JOURNAL;
RASH;
SHORT SURVEY;
ARTICLE;
DRUG APPROVAL;
UNITED STATES;
ANTI-HIV AGENTS;
CONTRACEPTIVES, POSTCOITAL;
DRUG APPROVAL;
ETHINYL ESTRADIOL;
HUMANS;
LEVONORGESTREL;
OXAZINES;
REVERSE TRANSCRIPTASE INHIBITORS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0032483672
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.280.17.1472-JFD80010-2-1 Document Type: Short Survey |
|
Times cited : (15)
|
|
References (0)
|